Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Owlet (OWLT) Long-Term Debt Issuances (2020 - 2025)

Owlet (OWLT) reported Long-Term Debt Issuances of $7.5 million for Q4 2025, little changed on a QoQ basis from $7.5 million in Q3 2024.

Owlet (OWLT) has 3 years of Long-Term Debt Issuances data on file, last reported at $7.5 million in Q4 2025.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $7.5 million, changed 0.0% from the prior year.
  • Long-Term Debt Issuances steadied at $7.5 million in Q4 2025 per OWLT's latest filing, from $7.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $7.5 million in Q3 2024 and bottomed at $7.5 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Owlet 150.10 Mn 109.09 Mn 12.24 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7.50 Mn
Dec 31, 2025 7.50 Mn
Sep 30, 2024 7.50 Mn
Sep 30, 2024 7.50 Mn
Dec 31, 2020 250,000.00
Dec 31, 2020 250,000.00
Sep 30, 2020 250,000.00
Sep 30, 2020 250,000.00